ConvergeHEALTH™ CGT Vantage
Orchestrating cell and gene therapies to better manage patient treatment journeys
A configurable solution that simplifies the orchestration of cell and gene therapies with clear visibility into Chain of Identity (COI) and Chain of Custody (COC) across industry stakeholders.
Why ConvergeHEALTH™ CGT Vantage?
Transform the management of cell and gene therapy patient journeys
Cell and gene therapy (CGT) has emerged as one of the fastest growing industries within Life Sciences. With the CGT supply chain being more complex than traditional pharma—requiring more stakeholders and touchpoints—organizations can simplify and manage this end-to-end capability by asking:
- How do we reduce time spent on user training and processes?
- How do we improve process transparency and collaboration between Contract Development and Manufacturing Organizations (CDMOs) and manufacturers?
- How can organizations cut back on costs?
ConvergeHEALTH™ CGT Vantage is a cell orchestration solution designed to optimize coordination within the complex cell and gene therapy ecosystem, enabling effective management of end-to-end patient treatment journeys.
The features
Solution benefits
Interested in joining our team?
